Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. (Q33997642)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Patrick Souverein

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

A M Harmsze

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J W van Werkum

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

N J Breet

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H J Bouman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C M Hackeng

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H J T Ruven

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J M ten Berg

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

O H Klungel

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A de Boer

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

V H M Deneer

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

1 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1892-1901

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21854540%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Calcium-channel blockers reduce the antiplatelet effect of clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Effects of CYP2C19 genotype on outcomes of clopidogrel treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Proton pump inhibitors and clopidogrel: putting the interaction in perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Clopidogrel with or without omeprazole in coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04483.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33997642&oldid=1532117884"